These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 18582807

  • 1. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 2. [Myocardial catecholamine content in heart failure--I: Regional distribution in explanted hearts. Comparison between dilated cardiomyopathy and coronary heart disease].
    Regitz V, Sasse S, Bossaller C, Strasser R, Schüler S, Hetzer R, Fleck E.
    Z Kardiol; 1989 Dec; 78(12):751-8. PubMed ID: 2623916
    [Abstract] [Full Text] [Related]

  • 3. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy.
    Karch R, Neumann F, Ullrich R, Neumüller J, Podesser BK, Neumann M, Schreiner W.
    Cardiovasc Pathol; 2005 Dec; 14(3):135-44. PubMed ID: 15914298
    [Abstract] [Full Text] [Related]

  • 4. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
    Erbs S, Gielen S, Linke A, Möbius-Winkler S, Adams V, Baither Y, Schuler G, Hambrecht R.
    Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196
    [Abstract] [Full Text] [Related]

  • 5. Increased Ca2+ sensitivity of myofibrillar tension in ischaemic vs dilated cardiomyopathy.
    Lee S, Lu R, Müller-Ehmsen J, Schwinger RH, Brixius K.
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1134-8. PubMed ID: 20804510
    [Abstract] [Full Text] [Related]

  • 6. Atrial and vascular oxidative stress in patients with heart failure.
    Rochette L, Tatou E, Maupoil V, Zeller M, Cottin Y, Jazayeri S, Brenot R, Girard C, David M, Vergely C.
    Cell Physiol Biochem; 2011 Dec; 27(5):497-502. PubMed ID: 21691067
    [Abstract] [Full Text] [Related]

  • 7. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M, Staudt A, Choudhury S, Trimpert C, Herda LR, Klingel K, Kandolf R, Schultheiss HP, Kroemer HK, Völker U, Felix SB.
    Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
    [Abstract] [Full Text] [Related]

  • 8. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V, Matteucci M, Ribezzo M, Di Silvestre D, Brambilla F, Agostini S, Mauri P, Padeletti L, Pingitore A, Delsedime L, Rinaldi M, Recchia FA, Pucci A.
    J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256
    [Abstract] [Full Text] [Related]

  • 9. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment.
    Maack C, Kartes T, Kilter H, Schäfers HJ, Nickenig G, Böhm M, Laufs U.
    Circulation; 2003 Sep 30; 108(13):1567-74. PubMed ID: 12963641
    [Abstract] [Full Text] [Related]

  • 10. Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy.
    Plenz G, Song ZF, Reichenberg S, Tjan TD, Robenek H, Deng MC.
    Thorac Cardiovasc Surg; 1998 Aug 30; 46(4):213-6. PubMed ID: 9776495
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy.
    Dashkevich A, Bloch W, Antonyan A, Goebel H, Fries JU, Schlensak C, Beyersdorf F, Geissler HJ.
    Lymphology; 2010 Sep 30; 43(3):110-7. PubMed ID: 21226413
    [Abstract] [Full Text] [Related]

  • 12. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
    Vatta M, Stetson SJ, Jimenez S, Entman ML, Noon GP, Bowles NE, Towbin JA, Torre-Amione G.
    J Am Coll Cardiol; 2004 Mar 03; 43(5):811-7. PubMed ID: 14998622
    [Abstract] [Full Text] [Related]

  • 13. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.
    Herpel E, Pritsch M, Koch A, Dengler TJ, Schirmacher P, Schnabel PA.
    Histopathology; 2006 May 03; 48(6):736-47. PubMed ID: 16681691
    [Abstract] [Full Text] [Related]

  • 14. Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure.
    Notarius CF, Spaak J, Morris BL, Floras JS.
    J Card Fail; 2007 Aug 03; 13(6):470-5. PubMed ID: 17675061
    [Abstract] [Full Text] [Related]

  • 15. [Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure].
    Oldenburg O, Lamp B, Töpfer V, Faber L, Teschler H, Horstkotte D.
    Dtsch Med Wochenschr; 2007 Mar 30; 132(13):661-6. PubMed ID: 17377879
    [Abstract] [Full Text] [Related]

  • 16. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M, Bilińska ZT, Mazurkiewicz Ł, Grzybowski J, Kruk M, Kurjata P, Piotrowski W, Ruzyłło W.
    Kardiol Pol; 2008 May 30; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [Abstract] [Full Text] [Related]

  • 17. Regional differences in myocardial work of the left ventricle in patients with idiopathic dilated cardiomyopathy: Implications for the surgical technique used for left ventriculoplasty.
    Yanagida R, Sugawara M, Kawai A, Koyanagi H.
    J Thorac Cardiovasc Surg; 2001 Sep 30; 122(3):600-7. PubMed ID: 11547316
    [Abstract] [Full Text] [Related]

  • 18. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T, Naya M, Manabe O, Wakasa S, Kubota S, Chiba S, Iwano H, Yamada S, Yoshinaga K, Tamaki N, Tsutsui H, Matsui Y.
    JACC Cardiovasc Imaging; 2011 Jul 30; 4(7):762-70. PubMed ID: 21757167
    [Abstract] [Full Text] [Related]

  • 19. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R, Abraham D, Paulus P, Blumer R, Grimm M, Wojta J, Aharinejad S.
    Circulation; 2003 Sep 30; 108(13):1585-91. PubMed ID: 12963640
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of echocardiographic findings in patients with coronary triple vessel disease and dilated cardiomyopathy].
    Nakamura H, Sawada H, Aizawa T, Watanabe H, Fujii J.
    J Cardiogr; 1985 Sep 30; 15(3):585-93. PubMed ID: 3837056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.